Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2019-03-01 Interim / Quarterly Rep…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim report' for Oasmia Pharmaceutical AB covering the period May 2018 to January 2019. It contains detailed financial statements (net sales, operating loss, net loss, loss per share), management commentary, and business activity updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-03-01 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension). It explicitly states the 'Reason for major shareholding notification Sell' and provides the 'Before the transaction' and 'After the transaction' details, including the resulting percentage (9.95%) and the number of shares (20,093,991). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document is short and appears to be the notification itself, not an announcement of a report.
2019-02-26 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension). It explicitly uses terms like 'Reason for major shareholding notification Buy', lists 'Shares', 'Voting rights', and 'Percentage' before and after the transaction, culminating in a 'Group total holdings' summary. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2019-02-12 English
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL) - UPDATED VERSION
AGM Information Classification · 98% confidence The document explicitly serves as a 'NOTICE OF THE EXTRAORDINARY GENERAL MEETING' (EGM). It details the date, time, location, registration procedures, and the agenda for the meeting. The agenda items focus on the 'Election of a new Board of Directors,' which is a core function of a general meeting. This clearly aligns with the definition of 'AGM Information' (AGM-R), even though it is an EGM, as it pertains to shareholder meetings and related materials. The presence of an attachment link for a 'PR Notice of EGM' further confirms this classification.
2019-02-05 English
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL) - UPDATED VERSION
AGM Information Classification · 98% confidence The document is explicitly titled 'NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL)'. It details the date, time, location, registration procedures, and the agenda for this meeting. The primary purpose is to convene shareholders to vote on matters, specifically the election of a new Board of Directors. This clearly aligns with the definition of materials shared during a General Meeting, which corresponds to the AGM-R code, even though it is an 'Extraordinary' meeting rather than an 'Annual' one, as AGM-R is the closest fit for general meeting materials among the provided options. It is not a proxy statement (PSI) as it is the notice itself, nor is it a DVA (Declaration of Voting Results) as the meeting has not yet occurred.
2019-02-05 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I OASMIA PHARMACEUTICAL AB (PUBL) - UPPDATERAD VERSION
AGM Information Classification · 99% confidence The document is explicitly titled "KALLELSE TILL EXTRA BOLAGSSTÄMMA I OASMIA PHARMACEUTICAL AB (PUBL)" which translates to 'NOTICE OF EXTRAORDINARY GENERAL MEETING'. It details the date, time, location, registration procedures, and the proposed agenda for a shareholder meeting, specifically called due to a request from shareholders representing over 10% of the shares to vote on the Board of Directors. This content perfectly matches the definition of an AGM-related document, specifically the notice/call for the meeting, which falls under the 'AGM Information' category (AGM-R). Although it is a notice, it is the primary document initiating the AGM process, making AGM-R the most appropriate classification over a general RPA or RNS.
2019-02-05 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.